| The role of the gut microbiome in colorectal cancer development and therapy response L Sánchez-Alcoholado, B Ramos-Molina, A Otero, A Laborda-Illanes, ... Cancers 12 (6), 1406, 2020 | 296 | 2020 |
| Dietary and gut microbiota polyamines in obesity-and age-related diseases B Ramos-Molina, MI Queipo-Ortuño, A Lambertos, FJ Tinahones, ... Frontiers in Nutrition 6, 24, 2019 | 180 | 2019 |
| PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders P Stijnen, B Ramos-Molina, S O'Rahilly, JWM Creemers Endocrine reviews 37 (4), 347-371, 2016 | 164 | 2016 |
| PCSK1 variants and human obesity B Ramos-Molina, MG Martin, I Lindberg Progress in molecular biology and translational science 140, 47-74, 2016 | 118 | 2016 |
| Metabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity M Clemente-Postigo, W Oliva-Olivera, L Coin-Aragüez, B Ramos-Molina, ... American Journal of Physiology-Endocrinology and Metabolism 316 (2), E319-E332, 2019 | 90 | 2019 |
| Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer L Sánchez-Alcoholado, R Ordóñez, A Otero, I Plaza-Andrade, ... International Journal of Molecular Sciences 21 (18), 6782, 2020 | 89 | 2020 |
| Non-alcoholic fatty liver disease in lean and non-obese individuals: current and future challenges MS Kuchay, JI Martínez-Montoro, NS Choudhary, JC Fernández-García, ... Biomedicines 9 (10), 1346, 2021 | 80 | 2021 |
| Altered adipose tissue DNA methylation status in metabolic syndrome: relationships between global DNA methylation and specific methylation at adipogenic, lipid metabolism and … D Castellano-Castillo, I Moreno-Indias, L Sanchez-Alcoholado, ... Journal of clinical medicine 8 (1), 87, 2019 | 78 | 2019 |
| Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition H Yamamoto, B Ramos-Molina, AN Lick, M Prideaux, V Albornoz, ... Bone 84, 120-130, 2016 | 67 | 2016 |
| Gut microbiota composition is associated with the global DNA methylation pattern in obesity B Ramos-Molina, L Sánchez-Alcoholado, A Cabrera-Mulero, ... Frontiers in genetics 10, 613, 2019 | 63 | 2019 |
| Leptin signaling in obesity and colorectal cancer CT Socol, A Chira, MA Martinez-Sanchez, MA Nuñez-Sanchez, ... International journal of molecular sciences 23 (9), 4713, 2022 | 62 | 2022 |
| The role of fatty acids in non-alcoholic fatty liver disease progression: An update A Hliwa, B Ramos-Molina, D Laski, A Mika, T Sledzinski International journal of molecular sciences 22 (13), 6900, 2021 | 59 | 2021 |
| Type 2 diabetes is associated with a different pattern of serum polyamines: a case–control study from the PREDIMED-Plus trial JC Fernandez-Garcia, A Delpino-Rius, I Samarra, D Castellano-Castillo, ... Journal of clinical medicine 8 (1), 71, 2019 | 48 | 2019 |
| Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: an altered liver-muscle crosstalk leading to increased mortality risk MS Kuchay, JI Martínez-Montoro, P Kaur, JC Fernández-García, ... Ageing Research Reviews 80, 101696, 2022 | 47 | 2022 |
| Antizyme inhibitor 2 (AZIN2/ODCp) stimulates polyamine uptake in mammalian cells AJ Lopez-Contreras, B Ramos-Molina, A Cremades, R Penafiel Journal of Biological Chemistry 283 (30), 20761-20769, 2008 | 43 | 2008 |
| Antizyme inhibitor 2: molecular, cellular and physiological aspects AJ López-Contreras, B Ramos-Molina, A Cremades, R Penafiel Amino Acids 38, 603-611, 2010 | 39 | 2010 |
| Cationic cell-penetrating peptides are potent furin inhibitors B Ramos-Molina, AN Lick, A Nasrolahi Shirazi, D Oh, R Tiwari, ... PloS one 10 (6), e0130417, 2015 | 37 | 2015 |
| Revisiting PC1/3 mutants: dominant-negative effect of endoplasmic reticulum-retained mutants EH Blanco, B Ramos-Molina, I Lindberg Endocrinology 156 (10), 3625-3637, 2015 | 33 | 2015 |
| Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma S Talamantes, M Lisjak, EH Gilglioni, CJ Llamoza-Torres, ... JHEP Reports 5 (9), 100811, 2023 | 28 | 2023 |
| Loss of Furin in β-Cells Induces an mTORC1-ATF4 anabolic pathway that leads to β-cell dysfunction B Brouwers, I Coppola, K Vints, B Dislich, N Jouvet, L Van Lommel, ... Diabetes 70 (2), 492-503, 2021 | 28 | 2021 |
Maria Isabel Queipo OrtuñoUniversidad de Málaga. Facultad de MedicinaE-mail megerősítve itt: uma.es